Glenmark Pharmaeuticals is poised to enter the US market and is expected to file 4-5 MDFs by March 2004 which the US Food and Drug Administration. Glenmark is also expected to file its first Abbreviated New Drug Application (ANDA) in the next two months while the rest of the applications will be filed by March 2004.
展开▼
